Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Scaled Net Operating Assets : 0.44 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Integrated Diagnostics Holdings's operating assets for the quarter that ended in Mar. 2024 was $121.99 Mil. Integrated Diagnostics Holdings's operating liabilities for the quarter that ended in Mar. 2024 was $39.53 Mil. Integrated Diagnostics Holdings's Total Assets for the quarter that ended in Dec. 2023 was $186.68 Mil. Therefore, Integrated Diagnostics Holdings's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.44.

Integrated Diagnostics Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Integrated Diagnostics Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Scaled Net Operating Assets Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.71

0.57

0.31

0.29

0.52

Integrated Diagnostics Holdings Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.44	0.33	0.41	0.63	0.44

Competitive Comparison of Integrated Diagnostics Holdings's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Diagnostics Holdings's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's Scaled Net Operating Assets falls into.

Integrated Diagnostics Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Integrated Diagnostics Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(158.837	-	48.214)	/	214.978
=	0.51

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	186.675	-	27.838
=	158.837

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	86.362	-	31.018	-	7.13
=	48.214

Integrated Diagnostics Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(121.986	-	39.529)	/	186.675
=	0.44

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	143.783	-	21.797
=	121.986

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	68.142	-	22.611	-	6.002
=	39.529

Integrated Diagnostics Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021